Copyright
©The Author(s) 2015.
World J Hepatol. Mar 27, 2015; 7(3): 406-424
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Published online Mar 27, 2015. doi: 10.4254/wjh.v7.i3.406
Table 1 Okuda
| Stage | Ascites | Tumor size | Albumin | Bilirubin | ||||
| (+) | (-) | > 50% | < 50% | < 3 g/dL | > 3 g/dL | > 3 mg/dL | ||
| (+) | (-) | (+) | (-) | (+) | ||||
| I(mildly advanced) | (-) | (-) | (-) | (-) | ||||
| II (moderately advanced) | One or two (+) | |||||||
| III (very advanced) | Three or four (+) | |||||||
- Citation: Kinoshita A, Onoda H, Fushiya N, Koike K, Nishino H, Tajiri H. Staging systems for hepatocellular carcinoma: Current status and future perspectives. World J Hepatol 2015; 7(3): 406-424
- URL: https://www.wjgnet.com/1948-5182/full/v7/i3/406.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i3.406